# BAY94-8862 Dose Finding Trial in Subjects With Chronic Heart Failure and Mild (Part A) or Moderate (Part B) Chronic Kidney Disease

> **NCT01345656** · PHASE2 · COMPLETED · sponsor: **Bayer** · enrollment: 457 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** BAY94-8862
- **DRUG:** BAY94-8862
- **DRUG:** BAY94-8862
- **DRUG:** BAY94-8862
- **DRUG:** Placebo
- **DRUG:** Spironolactone

## Key facts

- **NCT ID:** NCT01345656
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05-09
- **Primary completion:** 2012-05-30
- **Final completion:** 2012-07-16
- **Target enrollment:** 457 (ACTUAL)
- **Last updated:** 2022-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01345656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01345656, "BAY94-8862 Dose Finding Trial in Subjects With Chronic Heart Failure and Mild (Part A) or Moderate (Part B) Chronic Kidney Disease". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01345656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*